WallStreetZenWallStreetZen

NASDAQ: OBIO
Orchestra Biomed Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Orchestra Biomed Holdings revenue was $33.48M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $30.9M, up 3,490.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, OBIO annual revenue was $33.5M, with 1,169.2% growth year-over-year.

OBIO past revenue growth

How has OBIO's revenue growth performed historically?

Company
1,169.22%
Industry
373.35%
Market
89.03%
OBIO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OBIO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OBIO revenue history

Current Revenue
$33.5M
Current Earnings
-$53.0M
Current Profit Margin
-158.2%

Be the first to know when OBIO announces revenue.

OBIO Revenue History By Year

OBIO Yearly RevenueOBIO RevenueOBIO ChangeOBIO Revenue Growth
2025-12-31$33.48M$30.84M+1,169.22%
2024-12-31$2.64M-$122.00k-4.42%
2023-12-31$2.76M-$773.00k-21.88%
2022-12-31$3.53M$4.32M-551.79%
2021-12-31-$782.00k-$6.49M-113.71%
2020-12-31$5.70MN/AN/A

1 of 1

Orchestra Biomed Holdings Revenue FAQ

What was OBIO's revenue last quarter?

Orchestra Biomed Holdings (NASDAQ: OBIO) reported Q4 2025 revenue of $30.92 million up 12,120.16% year over year. In the same quarter last year, Orchestra Biomed Holdings's revenue was $253.00 thousand.

What was Orchestra Biomed Holdings's revenue in 2025?

Orchestra Biomed Holdings's annual revenue for the twelve months ending Dec 31, 2025 was $33.48 million, a 1,169.22% increase year over year.

How much does Orchestra Biomed Holdings make in a day?

Based on Orchestra Biomed Holdings annual revenue for the past five years, OBIO makes an average of $22,811.51 per day.

What was Orchestra Biomed Holdings's annual revenue growth in the past year?

As of Q1 2026, Orchestra Biomed Holdings's revenue has grown 1,169.22% year over year. This is 795.87 percentage points higher than the US Biotechnology industry revenue growth rate of 373.35%. Orchestra Biomed Holdings's revenue in the past year totaled $33.48 million.

How much does Orchestra Biomed Holdings make in a year?

Orchestra Biomed Holdings's revenue by year for the past five years is:
  • Orchestra Biomed Holdings's revenue for the twelve months ending Dec 31, 2025 was $33.48 million, a 1,169.22% increase year over year.
  • Orchestra Biomed Holdings's annual revenue for Dec 31, 2024 was $2.64 million, a 4.42% decrease from 2023.
  • Orchestra Biomed Holdings's annual revenue for 2023 was $2.76 million, a 21.88% decrease from 2022.
  • Orchestra Biomed Holdings's annual revenue for 2022 was $3.53 million, a 551.79% decrease from 2021.
  • Orchestra Biomed Holdings's annual revenue for 2021 was -$782.00 thousand, a 113.71% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.